Journal ID (nlm-ta): Front Cell Neurosci
Journal ID (iso-abbrev): Front Cell Neurosci
Journal ID (publisher-id): Front. Cell. Neurosci.
Title:
Frontiers in Cellular Neuroscience
Publisher:
Frontiers Media S.A.
ISSN
(Electronic):
1662-5102
Publication date
(Electronic):
05
May
2023
Publication date Collection: 2023
Volume: 17
Electronic Location Identifier: 1106287
Affiliations
[1]
1Technische Universität Dresden, Center for Regenerative Therapies Dresden (CRTD) , Dresden, Germany
[2]
2German Center for Neurodegenerative Diseases (DZNE) , Dresden, Germany
[3]
3Technische Universität Dresden, Center for Molecular and Cellular Bioengineering (CMCB),
Technology Platform Core Facility Electron Microscopy and Histology , Dresden, Germany
[4]
4Max Planck Institute of Molecular Cell Biology and Genetics , Dresden, Germany
[5]
5Technische Universität Dresden, Institute of Clinical Chemistry and Laboratory Medicine,
University Clinic Carl Gustav Carus , Dresden, Germany
[6]
6Technische Universität Dresden, Carl Gustav Carus Faculty of Medicine, Department
of Anesthesiology and Intensive Care Medicine, Clinical Sensoring and Monitoring , Dresden, Germany
Author notes
Edited by: David Hicks, Université de Strasbourg, France
Reviewed by: Karen Eastlake, University College London, United Kingdom; Laura Steenpass,
German Collection of Microorganisms and Cell Cultures GmbH (DSMZ), Germany
Article
DOI: 10.3389/fncel.2023.1106287
PMC ID: 10196395
PubMed ID: 37213216
SO-VID: c2484c14-e69e-47cd-9fe1-3503ac1adae5
Copyright © Copyright © 2023 Völkner, Wagner, Kurth, Sykes, Del Toro Runzer, Ebner, Kavak, Alexaki,
Cimalla, Mehner, Koch and Karl.
License:
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) and the copyright owner(s) are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Funded by: Deutsche Forschungsgemeinschaft, doi 10.13039/501100001659;
Award ID: KA2794/3-1
Award ID: KA2794/5-2
Award ID: KA2794/5-1
Funded by: Bundesministerium für Gesundheit, doi 10.13039/501100003107;
Award ID: 01EJ2206A
Award ID: 01EW2106
Funded by: Helmholtz-Gemeinschaft, doi 10.13039/501100001656;
This work was supported by the Funding Programs for DZNE Helmholtz (MK), TU Dresden
CRTD (MK), DFG KA2794/3-1 SPP1738 (MK), HGF ExNet-007 (MK), DFG KA2794/5-1 and KA2794/5-2
SPP2127 (MK), ERA-NET NEURON and BMBF 01EW2106, ReDiMoAMD (MK), BMBF PACETherapy,
01EJ2206A (MK), EyeNovative Award (Novartis Pharma GmbH) (MK), TU Dresden CRTD Seed
Grant (MK), and EFRE (EM-Facility, TK). The Article Processing Charges (APC) were
funded by the joint publication fund of the TU Dresden, the Medical Faculty Carl Gustav
Carus, and the SLUB Dresden. MK received funding from Novartis Pharma GmbH for this
study in the form of a research award, the EyeNovative Award, based on a research
project proposal. Novartis Pharma GmbH was not involved in the study, i.e., had no
role in study design, data collection and analysis, decision to publish, or preparation
of the manuscript.